The report has undergone several revisions to keep pace with evolving regulatory expectations and technological advancements: PDA TR13 Fundam Envioron Monitoring Program Revised2022

PDA members often receive significant discounts on technical reports or may have limited access to view them online as part of their membership benefits.

Development of EM programs based on . Selection of sampling sites and frequencies. Establishment of Alert and Action levels . Identification of microbial isolates. Investigation of out-of-specification results. How to Access It

PDA Technical Report 13 (TR13) provides guidance on pharmaceutical stability testing, a critical aspect of ensuring the quality and safety of pharmaceutical products. This report, published by the Parenteral Drug Association (PDA), outlines best practices for stability testing, including protocols, procedures, and data analysis. In this guide, we'll walk you through the key aspects of TR13 and provide information on how to access the report.

Many pharmaceutical companies maintain corporate licenses for PDA technical reports. If you are a professional in the field, check your company’s internal library or document management system.